SG Americas Securities’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SWTX
GCL
TAL
HI
BCM
MF
SG Americas Securities's SWTX Position: Q2 2025 in Review
SG Americas Securities sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 15,235 shares — an estimated $672K sold.
SG Americas Securities first reported a position in SWTX in Q1 2020 and held it in 15 quarters. The position peaked at $2.06M in Q4 2021. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.
- SG Americas Securities reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
- SG Americas Securities sold 15,235 SpringWorks Therapeutics shares in Q2 2025, an estimated $672K.
- SG Americas Securities first reported a position in SpringWorks Therapeutics in Q1 2020 and held it in 15 quarters.
- SG Americas Securities's SpringWorks Therapeutics position peaked at $2.06M in Q4 2021.
- 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.
Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.